| RMFCX | UIVAX | RMFCX / UIVAX | |
| Total Expense Ratio | 0.91 | 0.91 | 100% |
| Annual Report Gross Expense Ratio | 0.91 | 0.91 | 100% |
| Fund Existence | 24 years | 18 years | - |
| Gain YTD | 9.325 | 10.946 | 85% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 117B | 1.47B | 7,938% |
| Annual Yield % from dividends | 1.16 | 1.07 | 109% |
| Returns for 1 year | 9.56 | 10.54 | 91% |
| Returns for 3 years | 37.69 | 31.98 | 118% |
| Returns for 5 years | 38.62 | 25.81 | 150% |
| Returns for 10 years | 93.59 | 25.67 | 365% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TVRRX | 94.61 | 0.10 | +0.11% |
| Thornburg American Opportunities R5 | |||
| RIRAX | 83.09 | 0.02 | +0.02% |
| American Funds Capital Inc Bldr R-1 | |||
| RYOIX | 92.04 | N/A | N/A |
| Rydex Biotechnology Inv | |||
| FRAAX | 57.38 | N/A | N/A |
| Franklin Growth Opportunities Adv | |||
| CFCYX | 15.84 | -0.04 | -0.25% |
| Columbia Flexible Capital Income Inst3 | |||